244 related articles for article (PubMed ID: 7490298)
21. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.
Torrente Y; Tremblay JP; Pisati F; Belicchi M; Rossi B; Sironi M; Fortunato F; El Fahime M; D'Angelo MG; Caron NJ; Constantin G; Paulin D; Scarlato G; Bresolin N
J Cell Biol; 2001 Jan; 152(2):335-48. PubMed ID: 11266450
[TBL] [Abstract][Full Text] [Related]
22. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
23. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
Fakhfakh R; Michaud A; Tremblay JP
Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
[TBL] [Abstract][Full Text] [Related]
24. Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides.
Rando TA; Disatnik MH; Zhou LZ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5363-8. PubMed ID: 10805797
[TBL] [Abstract][Full Text] [Related]
25. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
[TBL] [Abstract][Full Text] [Related]
26. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
[TBL] [Abstract][Full Text] [Related]
27. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection.
Huard J; Roy R; Guérette B; Verreault S; Tremblay G; Tremblay JP
Muscle Nerve; 1994 Feb; 17(2):224-34. PubMed ID: 8114793
[TBL] [Abstract][Full Text] [Related]
28. [Mesenchymal stem cells transplanted in mdx mice differentiate into myocytes and express dystrophin/utrophin].
Feng SW; Zhang C; Lu XL; Liu TY; Li CM; Yao XL; Yu MJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):974-8. PubMed ID: 19460724
[TBL] [Abstract][Full Text] [Related]
29. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
Mueller GM; O'Day T; Watchko JF; Ontell M
Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
[TBL] [Abstract][Full Text] [Related]
30. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin prduced only a relatively small increase of dystrophin-positive membrane.
Kinoshita I; Vilquin JT; Asselin I; Chamberlain J; Tremblay JP
Muscle Nerve; 1998 Jan; 21(1):91-103. PubMed ID: 9427228
[TBL] [Abstract][Full Text] [Related]
33. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
[TBL] [Abstract][Full Text] [Related]
34. [Study of myoblast culture and myoblast transfer therapy in dystrophic mice].
Jong HJ; Chen SS; Chuang YH; Chen TJ
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):398-408. PubMed ID: 7650779
[TBL] [Abstract][Full Text] [Related]
35. In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression.
Chretien F; Dreyfus PA; Christov C; Caramelle P; Lagrange JL; Chazaud B; Gherardi RK
Am J Pathol; 2005 Jun; 166(6):1741-8. PubMed ID: 15920159
[TBL] [Abstract][Full Text] [Related]
36. Lack of myoblasts migration between transplanted and host muscles of mdx and normal mice.
Moens PD; Van-Schoor MC; Maréchal G
J Muscle Res Cell Motil; 1996 Feb; 17(1):37-43. PubMed ID: 8740430
[TBL] [Abstract][Full Text] [Related]
37. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors.
Cai B; Spencer MJ; Nakamura G; Tseng-Ong L; Tidball JG
Am J Pathol; 2000 May; 156(5):1789-96. PubMed ID: 10793090
[TBL] [Abstract][Full Text] [Related]
38. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice.
Benabdallah BF; Bouchentouf M; Rousseau J; Bigey P; Michaud A; Chapdelaine P; Scherman D; Tremblay JP
Cell Transplant; 2008; 17(3):337-50. PubMed ID: 18522236
[TBL] [Abstract][Full Text] [Related]
40. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
